nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranolazine—P-Glycoprotein Inhibitors—Vemurafenib—skin cancer	0.775	1	CiPCiCtD
Ranolazine—CYP3A4—Imiquimod—skin cancer	0.0351	0.233	CbGbCtD
Ranolazine—CYP3A4—Temozolomide—skin cancer	0.0351	0.233	CbGbCtD
Ranolazine—CYP2D6—Vemurafenib—skin cancer	0.0302	0.201	CbGbCtD
Ranolazine—CYP3A4—Vismodegib—skin cancer	0.0243	0.162	CbGbCtD
Ranolazine—CYP3A4—Vemurafenib—skin cancer	0.0192	0.128	CbGbCtD
Ranolazine—CYP3A4—Docetaxel—skin cancer	0.00659	0.0438	CbGbCtD
Ranolazine—Levobupivacaine—SCN10A—skin cancer	0.00129	0.409	CrCbGaD
Ranolazine—Bupivacaine—SCN10A—skin cancer	0.00103	0.327	CrCbGaD
Ranolazine—Ropivacaine—SCN10A—skin cancer	0.000829	0.264	CrCbGaD
Ranolazine—Pruritus—Vismodegib—skin cancer	0.000331	0.00461	CcSEcCtD
Ranolazine—Eye disorder—Imiquimod—skin cancer	0.000324	0.00452	CcSEcCtD
Ranolazine—Tinnitus—Imiquimod—skin cancer	0.000323	0.00451	CcSEcCtD
Ranolazine—Hot flush—Temozolomide—skin cancer	0.000321	0.00447	CcSEcCtD
Ranolazine—Amnesia—Temozolomide—skin cancer	0.00032	0.00446	CcSEcCtD
Ranolazine—Menopausal symptoms—Temozolomide—skin cancer	0.000318	0.00444	CcSEcCtD
Ranolazine—Angiopathy—Imiquimod—skin cancer	0.000314	0.00438	CcSEcCtD
Ranolazine—Mediastinal disorder—Imiquimod—skin cancer	0.000312	0.00435	CcSEcCtD
Ranolazine—Arrhythmia—Imiquimod—skin cancer	0.00031	0.00432	CcSEcCtD
Ranolazine—Disorientation—Fluorouracil—skin cancer	0.000309	0.00431	CcSEcCtD
Ranolazine—Cough—Vemurafenib—skin cancer	0.000309	0.0043	CcSEcCtD
Ranolazine—Mental disorder—Imiquimod—skin cancer	0.000304	0.00423	CcSEcCtD
Ranolazine—Malnutrition—Imiquimod—skin cancer	0.000302	0.00421	CcSEcCtD
Ranolazine—Diplopia—Temozolomide—skin cancer	0.0003	0.00419	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.000299	0.00417	CcSEcCtD
Ranolazine—Vomiting—Vismodegib—skin cancer	0.000297	0.00414	CcSEcCtD
Ranolazine—Rash—Vismodegib—skin cancer	0.000295	0.00411	CcSEcCtD
Ranolazine—Amnesia—Fluorouracil—skin cancer	0.000294	0.0041	CcSEcCtD
Ranolazine—Dermatitis—Vismodegib—skin cancer	0.000294	0.0041	CcSEcCtD
Ranolazine—Pancytopenia—Bleomycin—skin cancer	0.000292	0.00407	CcSEcCtD
Ranolazine—Hearing impaired—Docetaxel—skin cancer	0.000289	0.00403	CcSEcCtD
Ranolazine—Nervous system disorder—Vemurafenib—skin cancer	0.000283	0.00395	CcSEcCtD
Ranolazine—Lethargy—Fluorouracil—skin cancer	0.000282	0.00394	CcSEcCtD
Ranolazine—Skin disorder—Vemurafenib—skin cancer	0.00028	0.00391	CcSEcCtD
Ranolazine—Dehydration—Temozolomide—skin cancer	0.000279	0.00389	CcSEcCtD
Ranolazine—Weight decreased—Bleomycin—skin cancer	0.000278	0.00388	CcSEcCtD
Ranolazine—Nausea—Vismodegib—skin cancer	0.000278	0.00387	CcSEcCtD
Ranolazine—Angioedema—Imiquimod—skin cancer	0.000276	0.00384	CcSEcCtD
Ranolazine—Pancytopenia—Dactinomycin—skin cancer	0.000272	0.0038	CcSEcCtD
Ranolazine—Breast disorder—Temozolomide—skin cancer	0.000271	0.00378	CcSEcCtD
Ranolazine—Syncope—Imiquimod—skin cancer	0.000271	0.00377	CcSEcCtD
Ranolazine—Hypotension—Vemurafenib—skin cancer	0.00027	0.00376	CcSEcCtD
Ranolazine—Palpitations—Imiquimod—skin cancer	0.000267	0.00372	CcSEcCtD
Ranolazine—Loss of consciousness—Imiquimod—skin cancer	0.000265	0.0037	CcSEcCtD
Ranolazine—Cough—Imiquimod—skin cancer	0.000263	0.00367	CcSEcCtD
Ranolazine—Haematuria—Bleomycin—skin cancer	0.000262	0.00365	CcSEcCtD
Ranolazine—Anxiety—Imiquimod—skin cancer	0.000256	0.00357	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.000255	0.00356	CcSEcCtD
Ranolazine—Dry mouth—Imiquimod—skin cancer	0.000251	0.0035	CcSEcCtD
Ranolazine—Decreased appetite—Vemurafenib—skin cancer	0.000251	0.0035	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000249	0.00348	CcSEcCtD
Ranolazine—Fatigue—Vemurafenib—skin cancer	0.000249	0.00347	CcSEcCtD
Ranolazine—Constipation—Vemurafenib—skin cancer	0.000247	0.00344	CcSEcCtD
Ranolazine—Pancytopenia—Temozolomide—skin cancer	0.000246	0.00344	CcSEcCtD
Ranolazine—Hypoaesthesia—Bleomycin—skin cancer	0.000245	0.00342	CcSEcCtD
Ranolazine—Dysuria—Temozolomide—skin cancer	0.000243	0.00338	CcSEcCtD
Ranolazine—Shock—Imiquimod—skin cancer	0.000242	0.00338	CcSEcCtD
Ranolazine—Nervous system disorder—Imiquimod—skin cancer	0.000242	0.00337	CcSEcCtD
Ranolazine—Skin disorder—Imiquimod—skin cancer	0.000239	0.00333	CcSEcCtD
Ranolazine—Erectile dysfunction—Temozolomide—skin cancer	0.000239	0.00333	CcSEcCtD
Ranolazine—Hyperhidrosis—Imiquimod—skin cancer	0.000238	0.00332	CcSEcCtD
Ranolazine—Eosinophilia—Fluorouracil—skin cancer	0.000237	0.0033	CcSEcCtD
Ranolazine—Weight decreased—Temozolomide—skin cancer	0.000235	0.00327	CcSEcCtD
Ranolazine—Anorexia—Imiquimod—skin cancer	0.000235	0.00327	CcSEcCtD
Ranolazine—Pancytopenia—Fluorouracil—skin cancer	0.000227	0.00317	CcSEcCtD
Ranolazine—Insomnia—Imiquimod—skin cancer	0.000223	0.00311	CcSEcCtD
Ranolazine—Paraesthesia—Imiquimod—skin cancer	0.000221	0.00308	CcSEcCtD
Ranolazine—Dyspnoea—Imiquimod—skin cancer	0.00022	0.00306	CcSEcCtD
Ranolazine—Somnolence—Imiquimod—skin cancer	0.000219	0.00305	CcSEcCtD
Ranolazine—Dyspepsia—Imiquimod—skin cancer	0.000217	0.00302	CcSEcCtD
Ranolazine—Decreased appetite—Imiquimod—skin cancer	0.000214	0.00298	CcSEcCtD
Ranolazine—Hot flush—Docetaxel—skin cancer	0.000213	0.00298	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Imiquimod—skin cancer	0.000213	0.00296	CcSEcCtD
Ranolazine—Fatigue—Imiquimod—skin cancer	0.000212	0.00296	CcSEcCtD
Ranolazine—Menopausal symptoms—Docetaxel—skin cancer	0.000212	0.00295	CcSEcCtD
Ranolazine—Visual disturbance—Docetaxel—skin cancer	0.000211	0.00294	CcSEcCtD
Ranolazine—Asthenia—Vemurafenib—skin cancer	0.000207	0.00289	CcSEcCtD
Ranolazine—Hallucination—Temozolomide—skin cancer	0.000207	0.00288	CcSEcCtD
Ranolazine—Hypoaesthesia—Temozolomide—skin cancer	0.000207	0.00288	CcSEcCtD
Ranolazine—Urinary tract disorder—Temozolomide—skin cancer	0.000205	0.00286	CcSEcCtD
Ranolazine—Oedema peripheral—Temozolomide—skin cancer	0.000205	0.00285	CcSEcCtD
Ranolazine—Pruritus—Vemurafenib—skin cancer	0.000204	0.00285	CcSEcCtD
Ranolazine—Connective tissue disorder—Temozolomide—skin cancer	0.000204	0.00285	CcSEcCtD
Ranolazine—Lethargy—Docetaxel—skin cancer	0.000204	0.00284	CcSEcCtD
Ranolazine—Urethral disorder—Temozolomide—skin cancer	0.000204	0.00284	CcSEcCtD
Ranolazine—Feeling abnormal—Imiquimod—skin cancer	0.000203	0.00283	CcSEcCtD
Ranolazine—Gastrointestinal pain—Imiquimod—skin cancer	0.000201	0.00281	CcSEcCtD
Ranolazine—Epistaxis—Fluorouracil—skin cancer	0.000201	0.0028	CcSEcCtD
Ranolazine—Visual impairment—Temozolomide—skin cancer	0.0002	0.00279	CcSEcCtD
Ranolazine—Pain in extremity—Docetaxel—skin cancer	0.0002	0.00278	CcSEcCtD
Ranolazine—Urticaria—Imiquimod—skin cancer	0.000196	0.00273	CcSEcCtD
Ranolazine—Abdominal pain—Imiquimod—skin cancer	0.000195	0.00271	CcSEcCtD
Ranolazine—Eye disorder—Temozolomide—skin cancer	0.000194	0.00271	CcSEcCtD
Ranolazine—Tinnitus—Temozolomide—skin cancer	0.000194	0.0027	CcSEcCtD
Ranolazine—Cardiac disorder—Temozolomide—skin cancer	0.000193	0.00269	CcSEcCtD
Ranolazine—Leukopenia—Bleomycin—skin cancer	0.000192	0.00267	CcSEcCtD
Ranolazine—Dizziness—Vemurafenib—skin cancer	0.000191	0.00266	CcSEcCtD
Ranolazine—Hypoaesthesia—Fluorouracil—skin cancer	0.00019	0.00265	CcSEcCtD
Ranolazine—Angiopathy—Temozolomide—skin cancer	0.000188	0.00263	CcSEcCtD
Ranolazine—Mediastinal disorder—Temozolomide—skin cancer	0.000187	0.00261	CcSEcCtD
Ranolazine—Cough—Bleomycin—skin cancer	0.000187	0.00261	CcSEcCtD
Ranolazine—Dehydration—Docetaxel—skin cancer	0.000186	0.00259	CcSEcCtD
Ranolazine—Vomiting—Vemurafenib—skin cancer	0.000184	0.00256	CcSEcCtD
Ranolazine—Orthostatic hypotension—Docetaxel—skin cancer	0.000182	0.00254	CcSEcCtD
Ranolazine—Rash—Vemurafenib—skin cancer	0.000182	0.00254	CcSEcCtD
Ranolazine—Mental disorder—Temozolomide—skin cancer	0.000182	0.00254	CcSEcCtD
Ranolazine—Dermatitis—Vemurafenib—skin cancer	0.000182	0.00254	CcSEcCtD
Ranolazine—Headache—Vemurafenib—skin cancer	0.000181	0.00252	CcSEcCtD
Ranolazine—Malnutrition—Temozolomide—skin cancer	0.000181	0.00252	CcSEcCtD
Ranolazine—Breast disorder—Docetaxel—skin cancer	0.00018	0.00252	CcSEcCtD
Ranolazine—Cramp muscle—Docetaxel—skin cancer	0.00018	0.00251	CcSEcCtD
Ranolazine—Leukopenia—Dactinomycin—skin cancer	0.000179	0.00249	CcSEcCtD
Ranolazine—Asthenia—Imiquimod—skin cancer	0.000177	0.00246	CcSEcCtD
Ranolazine—Confusional state—Bleomycin—skin cancer	0.000176	0.00246	CcSEcCtD
Ranolazine—Pruritus—Imiquimod—skin cancer	0.000174	0.00243	CcSEcCtD
Ranolazine—Nausea—Vemurafenib—skin cancer	0.000172	0.00239	CcSEcCtD
Ranolazine—Thrombocytopenia—Bleomycin—skin cancer	0.000171	0.00239	CcSEcCtD
Ranolazine—Arrhythmia—Fluorouracil—skin cancer	0.000171	0.00238	CcSEcCtD
Ranolazine—Vision blurred—Temozolomide—skin cancer	0.00017	0.00238	CcSEcCtD
Ranolazine—Tremor—Temozolomide—skin cancer	0.000169	0.00236	CcSEcCtD
Ranolazine—Anorexia—Bleomycin—skin cancer	0.000167	0.00232	CcSEcCtD
Ranolazine—Angioedema—Temozolomide—skin cancer	0.000165	0.0023	CcSEcCtD
Ranolazine—Pancytopenia—Docetaxel—skin cancer	0.000164	0.00228	CcSEcCtD
Ranolazine—Hypotension—Bleomycin—skin cancer	0.000163	0.00228	CcSEcCtD
Ranolazine—Dizziness—Imiquimod—skin cancer	0.000163	0.00227	CcSEcCtD
Ranolazine—Vertigo—Temozolomide—skin cancer	0.000162	0.00226	CcSEcCtD
Ranolazine—Leukopenia—Temozolomide—skin cancer	0.000162	0.00226	CcSEcCtD
Ranolazine—Palpitations—Temozolomide—skin cancer	0.00016	0.00223	CcSEcCtD
Ranolazine—Thrombocytopenia—Dactinomycin—skin cancer	0.00016	0.00223	CcSEcCtD
Ranolazine—Cough—Temozolomide—skin cancer	0.000158	0.0022	CcSEcCtD
Ranolazine—Paraesthesia—Bleomycin—skin cancer	0.000157	0.00219	CcSEcCtD
Ranolazine—Vision blurred—Fluorouracil—skin cancer	0.000157	0.00219	CcSEcCtD
Ranolazine—Vomiting—Imiquimod—skin cancer	0.000157	0.00218	CcSEcCtD
Ranolazine—Weight decreased—Docetaxel—skin cancer	0.000156	0.00218	CcSEcCtD
Ranolazine—Dyspnoea—Bleomycin—skin cancer	0.000156	0.00217	CcSEcCtD
Ranolazine—Anorexia—Dactinomycin—skin cancer	0.000156	0.00217	CcSEcCtD
Ranolazine—Rash—Imiquimod—skin cancer	0.000155	0.00216	CcSEcCtD
Ranolazine—Dermatitis—Imiquimod—skin cancer	0.000155	0.00216	CcSEcCtD
Ranolazine—Headache—Imiquimod—skin cancer	0.000154	0.00215	CcSEcCtD
Ranolazine—Anxiety—Temozolomide—skin cancer	0.000153	0.00214	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000153	0.00213	CcSEcCtD
Ranolazine—Decreased appetite—Bleomycin—skin cancer	0.000152	0.00212	CcSEcCtD
Ranolazine—Renal failure—Docetaxel—skin cancer	0.000151	0.00211	CcSEcCtD
Ranolazine—Dry mouth—Temozolomide—skin cancer	0.000151	0.0021	CcSEcCtD
Ranolazine—Leukopenia—Fluorouracil—skin cancer	0.000149	0.00208	CcSEcCtD
Ranolazine—Confusional state—Temozolomide—skin cancer	0.000149	0.00207	CcSEcCtD
Ranolazine—Nausea—Imiquimod—skin cancer	0.000146	0.00204	CcSEcCtD
Ranolazine—Epistaxis—Docetaxel—skin cancer	0.000145	0.00202	CcSEcCtD
Ranolazine—Nervous system disorder—Temozolomide—skin cancer	0.000145	0.00202	CcSEcCtD
Ranolazine—Thrombocytopenia—Temozolomide—skin cancer	0.000144	0.00201	CcSEcCtD
Ranolazine—Feeling abnormal—Bleomycin—skin cancer	0.000144	0.00201	CcSEcCtD
Ranolazine—Skin disorder—Temozolomide—skin cancer	0.000143	0.002	CcSEcCtD
Ranolazine—Hyperhidrosis—Temozolomide—skin cancer	0.000143	0.00199	CcSEcCtD
Ranolazine—Decreased appetite—Dactinomycin—skin cancer	0.000142	0.00198	CcSEcCtD
Ranolazine—Fatigue—Dactinomycin—skin cancer	0.000141	0.00196	CcSEcCtD
Ranolazine—Anorexia—Temozolomide—skin cancer	0.000141	0.00196	CcSEcCtD
Ranolazine—Urticaria—Bleomycin—skin cancer	0.000139	0.00194	CcSEcCtD
Ranolazine—Hypoaesthesia—Docetaxel—skin cancer	0.000137	0.00192	CcSEcCtD
Ranolazine—Confusional state—Fluorouracil—skin cancer	0.000137	0.00191	CcSEcCtD
Ranolazine—Urinary tract disorder—Docetaxel—skin cancer	0.000136	0.0019	CcSEcCtD
Ranolazine—Oedema peripheral—Docetaxel—skin cancer	0.000136	0.0019	CcSEcCtD
Ranolazine—Connective tissue disorder—Docetaxel—skin cancer	0.000136	0.00189	CcSEcCtD
Ranolazine—Urethral disorder—Docetaxel—skin cancer	0.000135	0.00189	CcSEcCtD
Ranolazine—Feeling abnormal—Dactinomycin—skin cancer	0.000134	0.00187	CcSEcCtD
Ranolazine—Insomnia—Temozolomide—skin cancer	0.000133	0.00186	CcSEcCtD
Ranolazine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000133	0.00186	CcSEcCtD
Ranolazine—Nervous system disorder—Fluorouracil—skin cancer	0.000133	0.00186	CcSEcCtD
Ranolazine—Thrombocytopenia—Fluorouracil—skin cancer	0.000133	0.00186	CcSEcCtD
Ranolazine—Visual impairment—Docetaxel—skin cancer	0.000133	0.00186	CcSEcCtD
Ranolazine—Paraesthesia—Temozolomide—skin cancer	0.000133	0.00185	CcSEcCtD
Ranolazine—Dyspnoea—Temozolomide—skin cancer	0.000132	0.00183	CcSEcCtD
Ranolazine—Somnolence—Temozolomide—skin cancer	0.000131	0.00183	CcSEcCtD
Ranolazine—Dyspepsia—Temozolomide—skin cancer	0.00013	0.00181	CcSEcCtD
Ranolazine—Anorexia—Fluorouracil—skin cancer	0.00013	0.00181	CcSEcCtD
Ranolazine—Eye disorder—Docetaxel—skin cancer	0.000129	0.0018	CcSEcCtD
Ranolazine—Abdominal pain—Dactinomycin—skin cancer	0.000129	0.0018	CcSEcCtD
Ranolazine—Decreased appetite—Temozolomide—skin cancer	0.000128	0.00179	CcSEcCtD
Ranolazine—Cardiac disorder—Docetaxel—skin cancer	0.000128	0.00179	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000127	0.00178	CcSEcCtD
Ranolazine—Fatigue—Temozolomide—skin cancer	0.000127	0.00177	CcSEcCtD
Ranolazine—Hypotension—Fluorouracil—skin cancer	0.000127	0.00177	CcSEcCtD
Ranolazine—Constipation—Temozolomide—skin cancer	0.000126	0.00176	CcSEcCtD
Ranolazine—Asthenia—Bleomycin—skin cancer	0.000126	0.00175	CcSEcCtD
Ranolazine—Angiopathy—Docetaxel—skin cancer	0.000125	0.00175	CcSEcCtD
Ranolazine—Mediastinal disorder—Docetaxel—skin cancer	0.000124	0.00174	CcSEcCtD
Ranolazine—Pruritus—Bleomycin—skin cancer	0.000124	0.00173	CcSEcCtD
Ranolazine—Arrhythmia—Docetaxel—skin cancer	0.000123	0.00172	CcSEcCtD
Ranolazine—Insomnia—Fluorouracil—skin cancer	0.000123	0.00171	CcSEcCtD
Ranolazine—Paraesthesia—Fluorouracil—skin cancer	0.000122	0.0017	CcSEcCtD
Ranolazine—Feeling abnormal—Temozolomide—skin cancer	0.000122	0.0017	CcSEcCtD
Ranolazine—Dyspnoea—Fluorouracil—skin cancer	0.000121	0.00169	CcSEcCtD
Ranolazine—Mental disorder—Docetaxel—skin cancer	0.000121	0.00169	CcSEcCtD
Ranolazine—Somnolence—Fluorouracil—skin cancer	0.000121	0.00169	CcSEcCtD
Ranolazine—Gastrointestinal pain—Temozolomide—skin cancer	0.000121	0.00168	CcSEcCtD
Ranolazine—Malnutrition—Docetaxel—skin cancer	0.00012	0.00168	CcSEcCtD
Ranolazine—Dyspepsia—Fluorouracil—skin cancer	0.00012	0.00167	CcSEcCtD
Ranolazine—Decreased appetite—Fluorouracil—skin cancer	0.000118	0.00165	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000117	0.00164	CcSEcCtD
Ranolazine—Urticaria—Temozolomide—skin cancer	0.000117	0.00163	CcSEcCtD
Ranolazine—Asthenia—Dactinomycin—skin cancer	0.000117	0.00163	CcSEcCtD
Ranolazine—Abdominal pain—Temozolomide—skin cancer	0.000117	0.00163	CcSEcCtD
Ranolazine—Muscle spasms—Docetaxel—skin cancer	0.000116	0.00161	CcSEcCtD
Ranolazine—Feeling abnormal—Fluorouracil—skin cancer	0.000112	0.00156	CcSEcCtD
Ranolazine—Vomiting—Bleomycin—skin cancer	0.000111	0.00155	CcSEcCtD
Ranolazine—Rash—Bleomycin—skin cancer	0.00011	0.00154	CcSEcCtD
Ranolazine—Dermatitis—Bleomycin—skin cancer	0.00011	0.00154	CcSEcCtD
Ranolazine—Urticaria—Fluorouracil—skin cancer	0.000108	0.00151	CcSEcCtD
Ranolazine—Syncope—Docetaxel—skin cancer	0.000108	0.0015	CcSEcCtD
Ranolazine—Leukopenia—Docetaxel—skin cancer	0.000108	0.0015	CcSEcCtD
Ranolazine—Palpitations—Docetaxel—skin cancer	0.000106	0.00148	CcSEcCtD
Ranolazine—Asthenia—Temozolomide—skin cancer	0.000106	0.00148	CcSEcCtD
Ranolazine—Loss of consciousness—Docetaxel—skin cancer	0.000106	0.00147	CcSEcCtD
Ranolazine—Cough—Docetaxel—skin cancer	0.000105	0.00146	CcSEcCtD
Ranolazine—Pruritus—Temozolomide—skin cancer	0.000104	0.00146	CcSEcCtD
Ranolazine—Nausea—Bleomycin—skin cancer	0.000104	0.00145	CcSEcCtD
Ranolazine—Vomiting—Dactinomycin—skin cancer	0.000104	0.00145	CcSEcCtD
Ranolazine—Rash—Dactinomycin—skin cancer	0.000103	0.00143	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000102	0.00142	CcSEcCtD
Ranolazine—Dry mouth—Docetaxel—skin cancer	0.0001	0.0014	CcSEcCtD
Ranolazine—Confusional state—Docetaxel—skin cancer	9.9e-05	0.00138	CcSEcCtD
Ranolazine—Dizziness—Temozolomide—skin cancer	9.76e-05	0.00136	CcSEcCtD
Ranolazine—Nausea—Dactinomycin—skin cancer	9.69e-05	0.00135	CcSEcCtD
Ranolazine—Shock—Docetaxel—skin cancer	9.66e-05	0.00135	CcSEcCtD
Ranolazine—Nervous system disorder—Docetaxel—skin cancer	9.62e-05	0.00134	CcSEcCtD
Ranolazine—Pruritus—Fluorouracil—skin cancer	9.62e-05	0.00134	CcSEcCtD
Ranolazine—Thrombocytopenia—Docetaxel—skin cancer	9.61e-05	0.00134	CcSEcCtD
Ranolazine—Skin disorder—Docetaxel—skin cancer	9.53e-05	0.00133	CcSEcCtD
Ranolazine—Vomiting—Temozolomide—skin cancer	9.38e-05	0.00131	CcSEcCtD
Ranolazine—Anorexia—Docetaxel—skin cancer	9.35e-05	0.0013	CcSEcCtD
Ranolazine—Rash—Temozolomide—skin cancer	9.31e-05	0.0013	CcSEcCtD
Ranolazine—Dermatitis—Temozolomide—skin cancer	9.3e-05	0.0013	CcSEcCtD
Ranolazine—Headache—Temozolomide—skin cancer	9.25e-05	0.00129	CcSEcCtD
Ranolazine—Hypotension—Docetaxel—skin cancer	9.17e-05	0.00128	CcSEcCtD
Ranolazine—Dizziness—Fluorouracil—skin cancer	8.99e-05	0.00125	CcSEcCtD
Ranolazine—Insomnia—Docetaxel—skin cancer	8.88e-05	0.00124	CcSEcCtD
Ranolazine—Paraesthesia—Docetaxel—skin cancer	8.81e-05	0.00123	CcSEcCtD
Ranolazine—Nausea—Temozolomide—skin cancer	8.77e-05	0.00122	CcSEcCtD
Ranolazine—Dyspnoea—Docetaxel—skin cancer	8.75e-05	0.00122	CcSEcCtD
Ranolazine—Somnolence—Docetaxel—skin cancer	8.72e-05	0.00122	CcSEcCtD
Ranolazine—Vomiting—Fluorouracil—skin cancer	8.65e-05	0.00121	CcSEcCtD
Ranolazine—Dyspepsia—Docetaxel—skin cancer	8.64e-05	0.0012	CcSEcCtD
Ranolazine—Rash—Fluorouracil—skin cancer	8.57e-05	0.0012	CcSEcCtD
Ranolazine—Dermatitis—Fluorouracil—skin cancer	8.57e-05	0.00119	CcSEcCtD
Ranolazine—Decreased appetite—Docetaxel—skin cancer	8.53e-05	0.00119	CcSEcCtD
Ranolazine—Headache—Fluorouracil—skin cancer	8.52e-05	0.00119	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Docetaxel—skin cancer	8.47e-05	0.00118	CcSEcCtD
Ranolazine—Fatigue—Docetaxel—skin cancer	8.46e-05	0.00118	CcSEcCtD
Ranolazine—Constipation—Docetaxel—skin cancer	8.39e-05	0.00117	CcSEcCtD
Ranolazine—Feeling abnormal—Docetaxel—skin cancer	8.09e-05	0.00113	CcSEcCtD
Ranolazine—Nausea—Fluorouracil—skin cancer	8.08e-05	0.00113	CcSEcCtD
Ranolazine—Gastrointestinal pain—Docetaxel—skin cancer	8.03e-05	0.00112	CcSEcCtD
Ranolazine—Abdominal pain—Docetaxel—skin cancer	7.76e-05	0.00108	CcSEcCtD
Ranolazine—Asthenia—Docetaxel—skin cancer	7.04e-05	0.000982	CcSEcCtD
Ranolazine—Pruritus—Docetaxel—skin cancer	6.94e-05	0.000968	CcSEcCtD
Ranolazine—Dizziness—Docetaxel—skin cancer	6.49e-05	0.000905	CcSEcCtD
Ranolazine—Vomiting—Docetaxel—skin cancer	6.24e-05	0.00087	CcSEcCtD
Ranolazine—Rash—Docetaxel—skin cancer	6.19e-05	0.000863	CcSEcCtD
Ranolazine—Dermatitis—Docetaxel—skin cancer	6.18e-05	0.000862	CcSEcCtD
Ranolazine—Headache—Docetaxel—skin cancer	6.15e-05	0.000857	CcSEcCtD
Ranolazine—Nausea—Docetaxel—skin cancer	5.83e-05	0.000813	CcSEcCtD
